Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 16OTHER_GOV 2NIH 2INDUSTRY 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

spartalizumab 2Rituximab 2tislelizumab 1pegylated granulocyte colony-stimulating factor 1pegaspargase 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Oxaliplatin 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Lenalidomide 1Idarubicin 1Gemcitabine 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × pegylated granulocyte colony-stimulating factor × Lymphoid × Clear all
NCT02953730 2016-11-03

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

ChineseAMS

Phase 4 Completed
9 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡